Mississippi Janumet Lawsuit Attorneys
Janumet is a prescription drug for patients with type 2 diabetes. Manufactured by Merck & Co. and approved for public use in 2007 by the FDA, the intent of the drug is to help lower patients’ blood sugar levels. By increasing insulin production based on food intake, Janumet would simultaneously decrease the amount of sugar produced by the liver. The breakdown of incretin hormones slows to increase insulin production. However, Mississippi Janumet lawsuit attorneys know that, for all its good intentions, Janumet has unforeseen dangers.
While the original intent of the drug was to help type 2 diabetes patients, other health issues are being raised. If you or a loved one are diabetic and are experiencing medical difficulties after being prescribed Janumet, you may need the advice of Mississippi Janumet lawsuit attorneys. With these attorneys’ assistance, you or your loved one will have access to experience with pharmaceutical litigation and knowledge of the law.
FDA Issues Warning of Risks
Several months after approving Janumet, the FDA issued a warning after cases were reported of patients being diagnosed with acute pancreatitis while taking Janumet. In total, approximately 88 cases were reported between October 2006 and February 2009—one month before the FDA approved the drug. Research has not been completed on patients that have a history of pancreatitis. Therefore, it is unknown whether these patients face a greater risk while taking Janumet. Nevertheless, the FDA believes that doctors and patients should know about the possible health risks of getting pancreatitis.
Health Risks to Patients
Patients with acute pancreatitis suffered from various symptoms that included:
- Pain in the upper abdominal region
- Pain radiating from the abdomen to the back
- Increased pain in the abdominal area after eating
- Nausea and vomiting
- Tenderness in the abdomen
In addition to acute pancreatitis, research has revealed that risks for pancreatic cancer increased for diabetic patients who were taking Janumet. Nearly 50,000 Americans are diagnosed with pancreatic cancer each year; close to 40,000 of those diagnosed cases end in death. As the fourth leading cause of cancer deaths in the U.S., adults who are taking Janumet should be aware of the potential risks.
Unfortunately, diagnosis of pancreatic cancer from taking Janumet is difficult to catch in the early stages. Chances of survival decrease once this deadly disease spreads from the pancreas to other areas of the body. Symptoms related to pancreatic cancer in patients taking Janumet usually include back pain, jaundice, weight loss, clay-colored stools, and dark urine.
If you or a loved one is on Janumet and experiencing any of these symptoms, you could have pancreatic cancer. Talk to your doctor about any concerns that you may have. Next, seek the advice of Mississippi Janumet Lawsuit Attorneys. The dedication of Mississippi Janumet Lawsuit Attorneys is to help anyone who has been harmed by this drug. In response to the FDA warning about the health risks associated with Janumet, Merck does not agree with the link between taking the drug and pancreatitis cases.
Seeking Help from Mississippi Janumet Lawsuit Attorneys
Personal injuries caused by Janumet can lead to expensive medical bills, pain and suffering, and even death. If you or your loved one is suffering from injuries caused by this drug, Mississippi Janumet lawsuit attorneys can help. Injury and death from prescription drugs happens to often in the U.S. Mississippi Janumet lawsuit Attorneys are familiar with dangerous diabetic drugs and will seek compensation from the manufacturer to right those wrongs.
Free Evaluation from Mississippi Janumet Lawsuit Attorneys
If you or a loved one has been diagnosed with acute pancreatitis or pancreatic cancer after taking Janumet, you should contact Mississippi Janumet lawsuit attorneys immediately. A free case evaluation by Mississippi Janumet lawsuit Attorneys will determine if you are entitled to compensation.
